Eplerenone For the Treatment of Chronic Central Serous Chorioretinopathy
NCT02153125 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2014-06-02
Summary
The aim of the study is to determine the efficacy and safety in treating patients with chronic central serous chorioretinopathy with the drug eplerenone.
Conditions
- Central Serous Chorioretinopathy
Interventions
- DRUG
-
Eplerenone
Sponsors & Collaborators
-
Tel-Aviv Sourasky Medical Center
lead OTHER_GOV
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-04-30
- Primary Completion
- 2015-06-30
Countries
- Israel
Study Locations
More Related Trials
-
Efficacy of Platelet-Rich Plasma Injection in Dry Eye Syndrome
NCT06831253 ·Status: RECRUITING ·Phase: NA
-
Oral Pilocarpine in the Treatment of the Dry Eye of Patients With Sjogrens Syndrome
NCT04470479 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Corneal Neurosensory Abnormalities in Patients With Sjögren's Dry Eye
NCT06411132 ·Status: TERMINATED
-
Tamsulosin for Thyroid Lid Retraction
NCT04359979 ·Status: UNKNOWN ·Phase: NA
-
Six Month Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal Neurostimulator
NCT02526290 ·Status: COMPLETED ·Phase: NA
-
Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome
NCT04819269 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome
NCT07277257 ·Status: RECRUITING ·Phase: PHASE4
-
Treatment for Presumed Ocular Histoplasmosis
NCT01790893 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)
NCT00548301 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Effectiveness of Oculeve Intranasal Lacrimal Neurostimulator in Participants With Dry Eye Syndrome
NCT02680158 ·Status: COMPLETED ·Phase: NA
-
Levocarnitine for Dry Eye in Sjogren's Syndrome
NCT03953703 ·Status: COMPLETED ·Phase: PHASE2
-
Intravitreal Aflibercept Injection (IAI) for Presumed Ocular Histoplasmosis Syndrome
NCT01578720 ·Status: COMPLETED ·Phase: PHASE1
-
Etanercept Therapy for Sjogren's Syndrome
NCT00001954 ·Status: COMPLETED ·Phase: PHASE2
-
Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye
NCT02257957 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Efficacy and Safety of LO2A Eye Drops for Symptomatic Improvement of Dry Eye in Patients With Sjögren's Syndrome
NCT03319420 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)
NCT00502073 ·Status: COMPLETED ·Phase: PHASE3
-
Topical Cyclosporine for Vernal Keratoconjunctivitis (VKC) in Rwanda
NCT01211327 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of the Efficacy of Ocular Dipyridamole in the Treatment of Dry Eye Symptomology in Subjects With Pterygium
NCT02782260 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of the TearCare System in Dry Eye Disease
NCT03588624 ·Status: COMPLETED ·Phase: NA
-
Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study
NCT04884217 ·Status: UNKNOWN ·Phase: PHASE2
-
Physician's Evaluation of Cyclosporine Ophthalmic Emulsion 0.05%
NCT00827255 ·Status: COMPLETED
-
Study to Assess the Safety and Patients' Satisfaction of Tears Again* in the Treatment of Dry Eye Symptoms
NCT00535054 ·Status: COMPLETED ·Phase: NA
-
Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops
NCT00001731 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease
NCT02004067 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye Disease
NCT05119920 ·Status: COMPLETED ·Phase: PHASE2